This is a single center, double-blinded, randomized, placebo controlled single ascending dose clinical study, with the primary purpose of evaluating the safety, tolerability, pharmacokinetics (PK), and immunohistochemistry of escalating intravenous doses of ORT247 in healthy volunteers.

A Phase 1 Single-Ascending-Dose Study of ORT247 in Healthy Volunteers

A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single-Ascending-Dose Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Intravenous ORT247 in Healthy Volunteers

Treatment Trials

Focus your search

A Phase 1 Single-Ascending-Dose Study of ORT247 in Healthy Volunteers

Description

Conditions